SIGN launches latest diabetes guidance
New guidance on the management of diabetes has been launched by the Scottish Intercollegiate Guidelines Network (SIGN).
The guidance covers lifestyle interventions, psychosocial issues, and the pharmacological management of both type 1 and type 2 diabetes. The management of cardiovascular, kidney and foot diseases in patients with diabetes, as well has guidelines on how to prevent visual impairment and manage diabetes in pregnancy.
The guidance was unveiled at the Diabetes in Scotland Conference earlier this week.
Click here to access the full guidance or quick reference guide.
Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments. However, any comments deemed to be libellous will be removed
